| COMPOSITION | |
|---|---|
| ETAMSYLATE | 250MG |
| TRANEXAMIC ACID | 250MG |
ETAMSYLATE & TRANEXAMIC ACID
VIBEMSYL T
| SPECIFICATION | |||
|---|---|---|---|
| FORM | TABLET | ||
| PACKING | 10×10 | ||
| PACKING TYPE | ALU ALU | ||
| MRP | |||
DESCRIPTION
Tranexamic Acid
Antifibrinolytic hemostatic used in severe hemorrhage.
SIDE EFFECTS
Tranexamic Acid
Oral LD<sub>50</sub> in mice is >10 gm/kg. Symptoms of overdosage may be nausea, vomiting, orthostatic symptoms and/or hypotension.
INDICATION
TRANEXAMIC ACID
For use in patients with hemophilia for short term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. It can also be used for excessive bleeding in menstruation, surgery, or trauma cases.